Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

35 results about "Trichoderma citrinoviride" patented technology

Lactone derivative derived from trichoderma citrinoviride and application thereof

The invention relates to a lactone derivative derived from trichoderma citrinoviride and application thereof. The compound contains a molecular skeleton of hetero-oxygen atom pentacyclic lactone, and two methyls on the ring are located at the same side of the molecule. Verified by experiments, the lactone derivative has excellent anti-tumor activity. Besides, the lactone derivative can be applied to preparation of a cell proliferation inhibition drug or an anti-tumor drug and used for anti-tumor research.
Owner:FUZHOU UNIV

Trichoderma citrinoviride and application thereof

ActiveCN105219650ASuppression of damping-offInhibition of pathogenic fungiBiocideFungiBiotechnologyMicroorganism
The invention discloses a trichoderma citrinoviride strain. The trichoderma citrinoviride strain is preserved in China General Microbiological Culture Collection Center (CGMCC), and the preservation number of the trichoderma citrinoviride strain is CGMCC No. 8722. The trichoderma citrinoviride strain has the advantages that the trichoderma citrinoviride strain dissolves pathogenic fungus cell walls through the self-produced fungal cell wall degrading enzyme, the trichoderma citrinoviride strain seeps into the cells of pathogenic fungi to form a large amount of branches and sexual structures, the growth of the pathogenic fungi is inhibited, and the pathogenic fungi die; the pathogenic fungi of pepper damping-off can be efficiently inhibited by the trichoderma citrinoviride strain, pepper damping-off is reduced, and the trichoderma citrinoviride strain can replace chemical pesticides to inhibit pepper damping-off while environmental protection is achieved.
Owner:SHANGHAI WANLIHUA BIOTECH

Strain capable of producing 1,4-beta-D-xylanase and application of strain

InactiveCN107058135AOpen up new avenuesSuit one's needsFungiHydrolasesFiltrationXylanase
The invention relates to a strain capable of producing 1,4-beta-D-xylanase and an application of the strain and can effectively solve the problem about production of 1,4-beta-D-xylanase to meet demands in industry. The method comprises steps as follows: a culture medium for enzyme production by fermentation is inoculated with the strain capable of producing 1,4-beta-D-xylanase, a fermentation broth of 1,4-beta-D-xylanase is obtained and centrifuged, ammonium sulfate is slowly dropwise added to a liquid supernatant and salted out overnight, a salting-out liquid is centrifuged, precipitates are taken and dissolved with a buffer solution, packing is performed, a buffer solution is taken as a balance solution for DAE FF gel filtration chromatography, active components are collected, packing is performed again, linear elution is performed with a balance buffer solution, active components are collected, the mass concentration of ammonium sulfate in the active components is adjusted to 40%, packing is performed, an ammonia sulfate buffer solution is taken as a balance solution for linear elution, active components are collected, salt is removed through dialysis, and dry powder of 1,4-beta-D-xylanase is obtained through freezing and suction drying. The strain capable of producing 1,4-beta-D-xylanase is a novel strain Trichoderma citrinoviride HL28-5 and has the efficacy of producing 1,4-beta-D-xylanase, and a new way of producing 1,4-beta-D-xylanase is exploited.
Owner:HENAN ACAD OF SCI INST OF BIOLOGY LIABILITY

Application of penilloenol E1 derived from Trichoderma citrinoviride in lung cancer

The invention discloses an application of penilloenol E1 derived from Trichoderma citrinoviride in lung cancer. The structure of the compound is characterized in that the structure contains a pentacycloamide molecule skeleton, and a carbonyl group connected C10 saturated fat long chain, N is connected with a methyl group, and two hydroxyl groups exist in the molecule. Experiments confirm that the above alkaloid compound has good inhibition activity to lung cancer cells, can be used for preparing lung cancer cell proliferation inhibition medicines or anti-lung cancer medicines, and is used for antitumor researches.
Owner:FUZHOU UNIV

Application of penicillium enol E1 deriving from trichoderma citrinoviride in preparation of anti-lymphoma drug

The invention relates to application of penicillium enol E1 deriving from trichoderma citrinoviride in preparation of an anti-lymphoma drug. The compound is structurally characterized by containing a molecular skeleton of pentacyclic amide and a carbonyl group connected with a deca-carbon saturated fat long chain, wherein a methyl group is connected with N, and a molecule comprises two hydroxyl groups. It is verified through experiments that the alkaloid compound has good inhibitory activity on lymphoma and can be used for preparing a drug for inhibiting lymphoma cell proliferation or the anti-lymphoma drug and used in anti-tumor research.
Owner:FUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products